{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,19]],"date-time":"2026-09-19T01:58:49Z","timestamp":1789783129160,"version":"4.0.1"},"reference-count":155,"publisher":"MDPI AG","issue":"1","license":[{"start":{"date-parts":[[2017,12,27]],"date-time":"2017-12-27T00:00:00Z","timestamp":1514332800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100000024","name":"Canadian Institutes of Health Research","doi-asserted-by":"publisher","award":["PPP-133377"],"award-info":[{"award-number":["PPP-133377"]}],"id":[{"id":"10.13039\/501100000024","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000024","name":"Canadian Institutes of Health Research","doi-asserted-by":"publisher","award":["HBF-143163"],"award-info":[{"award-number":["HBF-143163"]}],"id":[{"id":"10.13039\/501100000024","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000024","name":"Canadian Institutes of Health Research","doi-asserted-by":"publisher","award":["PJT-148704"],"award-info":[{"award-number":["PJT-148704"]}],"id":[{"id":"10.13039\/501100000024","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Richard and Edith Strauss Canadian Foundation","award":["Post-doctoral fellowship"],"award-info":[{"award-number":["Post-doctoral fellowship"]}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Viruses"],"abstract":"<jats:p>HIV-1 drug therapies can prevent disease progression but cannot eliminate HIV-1 viruses from an infected individual. While there is hope that elimination of HIV-1 can be achieved, several approaches to reach a functional cure (control of HIV-1 replication in the absence of drug therapy) are also under investigation. One of these approaches is the transplant of HIV-1 resistant cells expressing anti-HIV-1 RNAs, proteins or peptides. Small RNAs that use RNA interference pathways to target HIV-1 replication have emerged as competitive candidates for cell transplant therapy and have been included in all gene combinations that have so far entered clinical trials. Here, we review RNA interference pathways in mammalian cells and the design of therapeutic small RNAs that use these pathways to target pathogenic RNA sequences. Studies that have been performed to identify anti-HIV-1 RNA interference therapeutics are also reviewed and perspectives on their use in combination gene therapy to functionally cure HIV-1 infection are provided.<\/jats:p>","DOI":"10.3390\/v10010008","type":"journal-article","created":{"date-parts":[[2017,12,27]],"date-time":"2017-12-27T11:16:00Z","timestamp":1514373360000},"page":"8","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":34,"title":["RNA Interference Therapies for an HIV-1 Functional Cure"],"prefix":"10.3390","volume":"10","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-7724-2441","authenticated-orcid":false,"given":"Robert","family":"Scarborough","sequence":"first","affiliation":[{"name":"Lady Davis Institute for Medical Research, Montreal, QC H3T 1E2, Canada"},{"name":"Department of Microbiology and Immunology, McGill University, Montreal, QC H3A0G4, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4553-0836","authenticated-orcid":false,"given":"Anne","family":"Gatignol","sequence":"additional","affiliation":[{"name":"Lady Davis Institute for Medical Research, Montreal, QC H3T 1E2, Canada"},{"name":"Department of Microbiology and Immunology, McGill University, Montreal, QC H3A0G4, Canada"},{"name":"Department of Medicine, Division of Experimental Medicine, McGill University, Montreal, QC H3A0G4, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2017,12,27]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1016\/j.coph.2010.04.011","article-title":"Antiretroviral drugs","volume":"10","year":"2010","journal-title":"Curr. Opin. Pharmacol."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1016\/j.antiviral.2013.12.007","article-title":"Evolution of HIV treatment guidelines in high- and low-income countries: Converging recommendations","volume":"103","author":"Richardson","year":"2014","journal-title":"Antivir. Res."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"5458","DOI":"10.1128\/JVI.02524-09","article-title":"Antiretroviral therapy in the clinic","volume":"84","author":"Tsibris","year":"2010","journal-title":"J. Virol."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"1291","DOI":"10.1126\/science.278.5341.1291","article-title":"Recovery of replication-competent HIV despite prolonged suppression of plasma viremia","volume":"278","author":"Wong","year":"1997","journal-title":"Science"},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"1295","DOI":"10.1126\/science.278.5341.1295","article-title":"Identification of a reservoir for HIV-1 in patients on highly active antiretroviral therapy","volume":"278","author":"Finzi","year":"1997","journal-title":"Science"},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"512","DOI":"10.1038\/8394","article-title":"Latent infection of CD4+ T cells provides a mechanism for lifelong persistence of HIV-1, even in patients on effective combination therapy","volume":"5","author":"Finzi","year":"1999","journal-title":"Nat. Med."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1038\/nri3262","article-title":"Towards an HIV cure: A global scientific strategy","volume":"12","author":"Deeks","year":"2012","journal-title":"Nat. Rev. Immunol."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1016\/j.immuni.2012.01.014","article-title":"Stimulation of HIV-1-specific cytolytic T lymphocytes facilitates elimination of latent viral reservoir after virus reactivation","volume":"36","author":"Shan","year":"2012","journal-title":"Immunity"},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1172\/JCI86047","article-title":"Recent developments in the effort to cure HIV infection: Going beyond N = 1","volume":"126","author":"Siliciano","year":"2016","journal-title":"J. Clin. Investig."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"786","DOI":"10.1056\/NEJMc1413931","article-title":"Viremic relapse after HIV-1 remission in a perinatally infected child","volume":"372","author":"Luzuriaga","year":"2015","journal-title":"N. Engl. J. Med."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"1828","DOI":"10.1056\/NEJMoa1302976","article-title":"Absence of detectable HIV-1 viremia after treatment cessation in an infant","volume":"369","author":"Persaud","year":"2013","journal-title":"N. Engl. J. Med."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"e49","DOI":"10.1016\/S2352-3018(15)00232-5","article-title":"HIV-1 virological remission lasting more than 12 years after interruption of early antiretroviral therapy in a perinatally infected teenager enrolled in the French ANRS EPF-CO10 paediatric cohort: A case report","volume":"3","author":"Frange","year":"2016","journal-title":"Lancet HIV"},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1097\/COH.0000000000000123","article-title":"Posttreatment controllers: What do they tell us?","volume":"10","author":"Rouzioux","year":"2015","journal-title":"Curr. Opin. HIV AIDS"},{"key":"ref_14","doi-asserted-by":"crossref","unstructured":"Saez-Cirion, A., Bacchus, C., Hocqueloux, L., Avettand-Fenoel, V., Girault, I., Lecuroux, C., Potard, V., Versmisse, P., Melard, A., and Prazuck, T. (2013). Post-treatment HIV-1 controllers with a long-term virological remission after the interruption of early initiated antiretroviral therapy ANRS VISCONTI Study. PLoS Pathog., 9.","DOI":"10.1371\/journal.ppat.1003211"},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1586\/14787210.2016.1122525","article-title":"Didehydro-Cortistatin A: A new player in HIV-therapy?","volume":"14","author":"Mousseau","year":"2016","journal-title":"Expert Rev. Anti-Infect. Ther."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"e00465","DOI":"10.1128\/mBio.00465-15","article-title":"The Tat Inhibitor Didehydro-Cortistatin A Prevents HIV-1 Reactivation from Latency","volume":"6","author":"Mousseau","year":"2015","journal-title":"mBio"},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1080\/14760584.2017.1322513","article-title":"New challenges in therapeutic vaccines against HIV infection","volume":"16","author":"Leal","year":"2017","journal-title":"Expert Rev. Vaccines"},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1186\/s12981-016-0114-y","article-title":"Stem cell transplantation in strategies for curing HIV\/AIDS","volume":"13","author":"Hutter","year":"2016","journal-title":"AIDS Res. Ther."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"2791","DOI":"10.1182\/blood-2010-09-309591","article-title":"Evidence for the cure of HIV infection by CCR5\u039432\/\u039432 stem cell transplantation","volume":"117","author":"Allers","year":"2011","journal-title":"Blood"},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1016\/S0092-8674(00)80110-5","article-title":"Homozygous defect in HIV-1 coreceptor accounts for resistance of some multiply-exposed individuals to HIV-1 infection","volume":"86","author":"Liu","year":"1996","journal-title":"Cell"},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1038\/335395a0","article-title":"Gene therapy. Intracellular immunization","volume":"335","author":"Baltimore","year":"1988","journal-title":"Nature"},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"2889","DOI":"10.1073\/pnas.93.7.2889","article-title":"Expression of a protective gene-prolongs survival of T cells in human immunodeficiency virus-infected patients","volume":"93","author":"Woffendin","year":"1996","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"1201","DOI":"10.1073\/pnas.95.3.1201","article-title":"Enhanced T cell engraftment after retroviral delivery of an antiviral gene in HIV-infected individuals","volume":"95","author":"Ranga","year":"1998","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"2407","DOI":"10.1089\/hum.1998.9.16-2407","article-title":"A controlled, Phase 1 clinical trial to evaluate the safety and effects in HIV-1 infected humans of autologous lymphocytes transduced with a ribozyme that cleaves HIV-1 RNA","volume":"9","author":"Poeschla","year":"1998","journal-title":"Hum. Gene Ther."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"2255","DOI":"10.1089\/10430349950017239","article-title":"A phase I trial of autologous CD34+ hematopoietic progenitor cells transduced with an anti-HIV ribozyme","volume":"10","author":"Amado","year":"1999","journal-title":"Hum. Gene Ther."},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"368","DOI":"10.1182\/blood.V94.1.368.413a47_368_371","article-title":"A clinical trial of retroviral-mediated transfer of a rev-responsive element decoy gene into CD34(+) cells from the bone marrow of human immunodeficiency virus-1-infected children","volume":"94","author":"Kohn","year":"1999","journal-title":"Blood"},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/j.ymthe.2005.02.024","article-title":"Selective survival of peripheral blood lymphocytes in children with HIV-1 following delivery of an anti-HIV gene to bone marrow CD34(+) cells","volume":"12","author":"Podsakoff","year":"2005","journal-title":"Mol. Ther."},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"1065","DOI":"10.1089\/hum.2005.16.1065","article-title":"Preferential survival of CD4+ T lymphocytes engineered with anti-human immunodeficiency virus (HIV) genes in HIV-infected individuals","volume":"16","author":"Morgan","year":"2005","journal-title":"Hum. Gene Ther."},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"698","DOI":"10.1182\/blood.V99.2.698","article-title":"Nonmyeloablative conditioning followed by transplantation of genetically modified HLA-matched peripheral blood progenitor cells for hematologic malignancies in patients with acquired immunodeficiency syndrome","volume":"99","author":"Kang","year":"2002","journal-title":"Blood"},{"key":"ref_30","doi-asserted-by":"crossref","unstructured":"Hayakawa, J., Washington, K., Uchida, N., Phang, O., Kang, E.M., Hsieh, M.M., and Tisdale, J.F. (2009). Long-term vector integration site analysis following retroviral mediated gene transfer to hematopoietic stem cells for the treatment of HIV infection. PLoS ONE, 4.","DOI":"10.1371\/journal.pone.0004211"},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"1024","DOI":"10.1038\/mt.sj.6300124","article-title":"Transfer of autologous gene-modified T cells in HIV-infected patients with advanced immunodeficiency and drug-resistant virus","volume":"15","author":"Glaunsinger","year":"2007","journal-title":"Mol. Ther."},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"901","DOI":"10.1056\/NEJMoa1300662","article-title":"Gene editing of CCR5 in autologous CD4 T cells of persons infected with HIV","volume":"370","author":"Tebas","year":"2014","journal-title":"N. Engl. J. Med."},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"16067","DOI":"10.1038\/mtm.2016.67","article-title":"Preclinical development and qualification of ZFN-mediated CCR5 disruption in human hematopoietic stem\/progenitor cells","volume":"3","author":"DiGiusto","year":"2016","journal-title":"Mol. Ther. Methods Clin. Dev."},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"552","DOI":"10.1002\/jgm.705","article-title":"Long-term survival and concomitant gene expression of ribozyme-transduced CD4+ T-lymphocytes in HIV-infected patients","volume":"7","author":"Macpherson","year":"2005","journal-title":"J. Gene Med."},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1089\/104303404322886101","article-title":"Anti-human immunodeficiency virus hematopoietic progenitor cell-delivered ribozyme in a phase I study: Myeloid and lymphoid reconstitution in human immunodeficiency virus type-1-infected patients","volume":"15","author":"Amado","year":"2004","journal-title":"Hum. Gene Ther."},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1038\/nm.1932","article-title":"Phase 2 gene therapy trial of an anti-HIV ribozyme in autologous CD34+ cells","volume":"15","author":"Mitsuyasu","year":"2009","journal-title":"Nat. Med."},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1196\/annals.1281.008","article-title":"RNA-mediated inhibition of HIV in a gene therapy setting","volume":"1002","author":"Michienzi","year":"2003","journal-title":"Ann. N. Y. Acad. Sci."},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"17372","DOI":"10.1073\/pnas.0608138103","article-title":"Gene transfer in humans using a conditionally replicating lentiviral vector","volume":"103","author":"Levine","year":"2006","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"1524","DOI":"10.1182\/blood-2012-07-447250","article-title":"Antiviral effects of autologous CD4 T cells genetically modified with a conditionally replicating lentiviral vector expressing long antisense to HIV","volume":"121","author":"Tebas","year":"2013","journal-title":"Blood"},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"36ra43","DOI":"10.1126\/scitranslmed.3000931","article-title":"RNA-based gene therapy for HIV with lentiviral vector-modified CD34(+) cells in patients undergoing transplantation for AIDS-related lymphoma","volume":"2","author":"DiGiusto","year":"2010","journal-title":"Sci. Transl. Med."},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"5719","DOI":"10.1128\/JVI.06300-11","article-title":"Generation of an HIV-1-resistant immune system with CD34(+) hematopoietic stem cells transduced with a triple-combination anti-HIV lentiviral vector","volume":"86","author":"Walker","year":"2012","journal-title":"J. Virol."},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1089\/hum.2007.108","article-title":"Human immunodeficiency virus type 1 restriction by human-rhesus chimeric tripartite motif 5\u03b1 (TRIM 5\u03b1) in CD34(+) cell-derived macrophages in vitro and in T cells in vivo in severe combined immunodeficient (SCID-hu) mice transplanted with human fetal tissue","volume":"19","author":"Anderson","year":"2008","journal-title":"Hum. Gene Ther."},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"3910","DOI":"10.3390\/v7072804","article-title":"Bone Marrow Gene Therapy for HIV\/AIDS","volume":"7","author":"Berkhout","year":"2015","journal-title":"Viruses"},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"1782","DOI":"10.1016\/j.ymthe.2017.04.027","article-title":"CRISPR\/Cas9-Mediated CCR5 Ablation in Human Hematopoietic Stem\/Progenitor Cells Confers HIV-1 Resistance In Vivo","volume":"25","author":"Xu","year":"2017","journal-title":"Mol. Ther."},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1016\/j.chembiol.2011.12.008","article-title":"RNA-based therapeutics: Current progress and future prospects","volume":"19","author":"Burnett","year":"2012","journal-title":"Chem. Biol."},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1080\/15476286.2015.1014759","article-title":"HIV-1 RRE RNA acts as an RNA silencing suppressor by competing with TRBP-bound siRNAs","volume":"12","author":"Daniels","year":"2015","journal-title":"RNA Biol."},{"key":"ref_47","doi-asserted-by":"crossref","first-page":"952","DOI":"10.1038\/mt.2014.32","article-title":"Optimized lentiviral vectors for HIV gene therapy: Multiplexed expression of small RNAs and inclusion of MGMT(P140K) drug resistance gene","volume":"22","author":"Chung","year":"2014","journal-title":"Mol. Ther."},{"key":"ref_48","doi-asserted-by":"crossref","first-page":"1507","DOI":"10.3390\/ph6121507","article-title":"Aptamer-based therapeutics: New approaches to combat human viral diseases","volume":"6","author":"Shum","year":"2013","journal-title":"Pharmaceuticals (Basel)"},{"key":"ref_49","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1007\/978-1-62703-730-3_2","article-title":"Screening inhibitory potential of anti-HIV RT RNA aptamers","volume":"1103","author":"Lange","year":"2014","journal-title":"Methods Mol. Biol."},{"key":"ref_50","doi-asserted-by":"crossref","first-page":"e228","DOI":"10.1038\/mtna.2015.1","article-title":"High-affinity RNA Aptamers Against the HIV-1 Protease Inhibit Both In Vitro Protease Activity and Late Events of Viral Replication","volume":"4","author":"Duclair","year":"2015","journal-title":"Mol. Ther. Nucleic Acids"},{"key":"ref_51","doi-asserted-by":"crossref","unstructured":"Pang, K.M., Castanotto, D., Li, H., Scherer, L., and Rossi, J.J. (2017). Incorporation of aptamers in the terminal loop of shRNAs yields an effective and novel combinatorial targeting strategy. Nucleic Acids Res.","DOI":"10.1093\/nar\/gkx980"},{"key":"ref_52","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1128\/JVI.02626-09","article-title":"RNA aptamers directed to human immunodeficiency virus type 1 Gag polyprotein bind to the matrix and nucleocapsid domains and inhibit virus production","volume":"85","author":"Ramalingam","year":"2011","journal-title":"J. Virol."},{"key":"ref_53","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1146\/annurev.pharmtox.010909.105654","article-title":"RNA targeting therapeutics: Molecular mechanisms of antisense oligonucleotides as a therapeutic platform","volume":"50","author":"Bennett","year":"2010","journal-title":"Annu. Rev. Pharmacol. Toxicol."},{"key":"ref_54","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1007\/978-1-4939-2432-5_5","article-title":"HIV and Ribozymes","volume":"848","author":"Scarborough","year":"2015","journal-title":"Adv. Exp. Med. Biol."},{"key":"ref_55","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1089\/108729003764097296","article-title":"Comparison of the suppressive effects of antisense oligonucleotides and siRNAs directed against the same targets in mammalian cells","volume":"13","author":"Miyagishi","year":"2003","journal-title":"Antisense Nucleic Acid Drug Dev."},{"key":"ref_56","doi-asserted-by":"crossref","first-page":"806","DOI":"10.1038\/35888","article-title":"Potent and specific genetic interference by double-stranded RNA in Caenorhabditis elegans","volume":"391","author":"Fire","year":"1998","journal-title":"Nature"},{"key":"ref_57","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1016\/j.cell.2007.07.039","article-title":"Antiviral Immunity Directed by Small RNAs","volume":"130","author":"Ding","year":"2007","journal-title":"Cell"},{"key":"ref_58","doi-asserted-by":"crossref","first-page":"652","DOI":"10.1128\/MMBR.00012-12","article-title":"The multiple functions of TRBP, at the hub of cell responses to viruses, stress, and cancer","volume":"76","author":"Daniels","year":"2012","journal-title":"Microbiol. Mol. Biol. Rev."},{"key":"ref_59","doi-asserted-by":"crossref","first-page":"1151","DOI":"10.1101\/gad.1793309","article-title":"The role of RNAi and microRNAs in animal virus replication and antiviral immunity","volume":"23","author":"Umbach","year":"2009","journal-title":"Genes Dev."},{"key":"ref_60","doi-asserted-by":"crossref","first-page":"17052","DOI":"10.1038\/nmicrobiol.2017.52","article-title":"Questioning antiviral RNAi in mammals","volume":"2","author":"TenOever","year":"2017","journal-title":"Nat. Microbiol."},{"key":"ref_61","doi-asserted-by":"crossref","first-page":"374","DOI":"10.1016\/j.chom.2013.09.011","article-title":"Is RNA interference a physiologically relevant innate antiviral immune response in mammals?","volume":"14","author":"Cullen","year":"2013","journal-title":"Cell Host Microbe"},{"key":"ref_62","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1126\/science.1241911","article-title":"RNA interference functions as an antiviral immunity mechanism in mammals","volume":"342","author":"Li","year":"2013","journal-title":"Science"},{"key":"ref_63","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1126\/science.1241930","article-title":"Antiviral RNA interference in mammalian cells","volume":"342","author":"Maillard","year":"2013","journal-title":"Science"},{"key":"ref_64","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1126\/science.1245475","article-title":"Molecular biology. RNAi, Antiviral after all","volume":"342","author":"Sagan","year":"2013","journal-title":"Science"},{"key":"ref_65","doi-asserted-by":"crossref","first-page":"16250","DOI":"10.1038\/nmicrobiol.2016.250","article-title":"Induction and suppression of antiviral RNA interference by influenza A virus in mammalian cells","volume":"2","author":"Li","year":"2016","journal-title":"Nat. Microbiol."},{"key":"ref_66","doi-asserted-by":"crossref","first-page":"2505","DOI":"10.15252\/embj.201695086","article-title":"Inactivation of the type I interferon pathway reveals long double-stranded RNA-mediated RNA interference in mammalian cells","volume":"35","author":"Maillard","year":"2016","journal-title":"EMBO J."},{"key":"ref_67","doi-asserted-by":"crossref","first-page":"853","DOI":"10.1126\/science.1064921","article-title":"Identification of novel genes coding for small expressed RNAs","volume":"294","author":"Rauhut","year":"2001","journal-title":"Science"},{"key":"ref_68","doi-asserted-by":"crossref","first-page":"862","DOI":"10.1126\/science.1065329","article-title":"An extensive class of small RNAs in Caenorhabditis elegans","volume":"294","author":"Lee","year":"2001","journal-title":"Science"},{"key":"ref_69","doi-asserted-by":"crossref","first-page":"858","DOI":"10.1126\/science.1065062","article-title":"An abundant class of tiny RNAs with probable regulatory roles in Caenorhabditis elegans","volume":"294","author":"Lau","year":"2001","journal-title":"Science"},{"key":"ref_70","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1101\/gr.082701.108","article-title":"Most mammalian mRNAs are conserved targets of microRNAs","volume":"19","author":"Friedman","year":"2009","journal-title":"Genome Res."},{"key":"ref_71","doi-asserted-by":"crossref","first-page":"D68","DOI":"10.1093\/nar\/gkt1181","article-title":"miRBase: Annotating high confidence microRNAs using deep sequencing data","volume":"42","author":"Kozomara","year":"2014","journal-title":"Nucleic Acids Res."},{"key":"ref_72","doi-asserted-by":"crossref","first-page":"4051","DOI":"10.1038\/sj.emboj.7600385","article-title":"MicroRNA genes are transcribed by RNA polymerase II","volume":"23","author":"Lee","year":"2004","journal-title":"EMBO J."},{"key":"ref_73","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1126\/science.1090599","article-title":"Nuclear export of microRNA precursors","volume":"303","author":"Lund","year":"2004","journal-title":"Science"},{"key":"ref_74","doi-asserted-by":"crossref","unstructured":"Daniels, S.M., Melendez-Pe\u00f1a, C.E., Scarborough, R.J., Daher, A., Christensen, H.S., El Far, M., Purcell, D.F., Lain\u00e9, S., and Gatignol, A. (2009). Characterization of the TRBP domain required for dicer interaction and function in RNA interference. BMC Mol. Biol., 10.","DOI":"10.1186\/1471-2199-10-38"},{"key":"ref_75","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1146\/annurev.micro.112408.134243","article-title":"Viruses, microRNAs, and host interactions","volume":"64","author":"Skalsky","year":"2010","journal-title":"Annu. Rev. Microbiol."},{"key":"ref_76","doi-asserted-by":"crossref","first-page":"2353","DOI":"10.1093\/nar\/gkn076","article-title":"Identification of functional microRNAs released through asymmetrical processing of HIV-1 TAR element","volume":"36","author":"Ouellet","year":"2008","journal-title":"Nucleic Acids Res."},{"key":"ref_77","doi-asserted-by":"crossref","first-page":"1241","DOI":"10.1038\/nm1639","article-title":"Cellular microRNAs contribute to HIV-1 latency in resting primary CD4+ T lymphocytes","volume":"13","author":"Huang","year":"2007","journal-title":"Nat. Med."},{"key":"ref_78","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1186\/s13073-017-0450-0","article-title":"Advances in the delivery of RNA therapeutics: From concept to clinical reality","volume":"9","author":"Kaczmarek","year":"2017","journal-title":"Genome Med."},{"key":"ref_79","doi-asserted-by":"crossref","unstructured":"Adams, D., Suhr, O.B., Dyck, P.J., Litchy, W.J., Leahy, R.G., Chen, J., Gollob, J., and Coelho, T. (2017). Trial design and rationale for APOLLO, a Phase 3, placebo-controlled study of patisiran in patients with hereditary ATTR amyloidosis with polyneuropathy. BMC Neurol., 17.","DOI":"10.1186\/s12883-017-0948-5"},{"key":"ref_80","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1007\/s40259-017-0234-5","article-title":"Adeno-Associated Virus (AAV) as a Vector for Gene Therapy","volume":"31","author":"Naso","year":"2017","journal-title":"BioDrugs"},{"key":"ref_81","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1146\/annurev-bioeng-071813-104938","article-title":"Viral Vectors for Gene Therapy: Translational and Clinical Outlook","volume":"17","author":"Kotterman","year":"2015","journal-title":"Annu. Rev. Biomed. Eng."},{"key":"ref_82","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1016\/S0014-5793(00)01883-4","article-title":"Sensitive assay of RNA interference in Drosophila and Chinese hamster cultured cells using firefly luciferase gene as target","volume":"479","author":"Zenno","year":"2000","journal-title":"FEBS Lett."},{"key":"ref_83","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1016\/S0378-1119(00)00224-9","article-title":"dsRNA-mediated gene silencing in cultured Drosophila cells: A tissue culture model for the analysis of RNA interference","volume":"252","author":"Caplen","year":"2000","journal-title":"Gene"},{"key":"ref_84","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/S0092-8674(00)80620-0","article-title":"RNAi: Double-stranded RNA directs the ATP-dependent cleavage of mRNA at 21 to 23 nucleotide intervals","volume":"101","author":"Zamore","year":"2000","journal-title":"Cell"},{"key":"ref_85","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1038\/35005107","article-title":"An RNA-directed nuclease mediates post-transcriptional gene silencing in Drosophila cells","volume":"404","author":"Hammond","year":"2000","journal-title":"Nature"},{"key":"ref_86","doi-asserted-by":"crossref","first-page":"1077","DOI":"10.1016\/S1097-2765(00)00106-4","article-title":"Functional anatomy of a dsRNA trigger: Differential requirement for the two trigger strands in RNA interference","volume":"6","author":"Parrish","year":"2000","journal-title":"Mol. Cell"},{"key":"ref_87","doi-asserted-by":"crossref","first-page":"494","DOI":"10.1038\/35078107","article-title":"Duplexes of 21-nucleotide RNAs mediate RNA interference in cultured mammalian cells","volume":"411","author":"Elbashir","year":"2001","journal-title":"Nature"},{"key":"ref_88","doi-asserted-by":"crossref","first-page":"9742","DOI":"10.1073\/pnas.171251798","article-title":"Specific inhibition of gene expression by small double-stranded RNAs in invertebrate and vertebrate systems","volume":"98","author":"Caplen","year":"2001","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_89","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1016\/S0092-8674(03)00801-8","article-title":"Functional siRNAs and miRNAs exhibit strand bias","volume":"115","author":"Khvorova","year":"2003","journal-title":"Cell"},{"key":"ref_90","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1016\/S0092-8674(03)00759-1","article-title":"Asymmetry in the assembly of the RNAi enzyme complex","volume":"115","author":"Schwarz","year":"2003","journal-title":"Cell"},{"key":"ref_91","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1007\/978-1-62703-311-4_4","article-title":"siRNA design principles and off-target effects","volume":"986","author":"Petri","year":"2013","journal-title":"Methods Mol. Biol."},{"key":"ref_92","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1038\/nbt1051","article-title":"Synthetic dsRNA Dicer substrates enhance RNAi potency and efficacy","volume":"23","author":"Kim","year":"2005","journal-title":"Nat. Biotechnol."},{"key":"ref_93","doi-asserted-by":"crossref","first-page":"4140","DOI":"10.1093\/nar\/gki732","article-title":"Functional polarity is introduced by Dicer processing of short substrate RNAs","volume":"33","author":"Rose","year":"2005","journal-title":"Nucleic Acids Res."},{"key":"ref_94","doi-asserted-by":"crossref","first-page":"508","DOI":"10.1038\/nprot.2006.72","article-title":"Rational design and in vitro and in vivo delivery of Dicer substrate siRNA","volume":"1","author":"Amarzguioui","year":"2006","journal-title":"Nat. Protoc."},{"key":"ref_95","doi-asserted-by":"crossref","first-page":"6209","DOI":"10.1093\/nar\/gkt200","article-title":"Molecular basis for improved gene silencing by Dicer substrate interfering RNA compared with other siRNA variants","volume":"41","author":"Snead","year":"2013","journal-title":"Nucleic Acids Res."},{"key":"ref_96","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1261\/rna.031120.111","article-title":"Comprehensive evaluation of canonical versus Dicer-substrate siRNA in vitro and in vivo","volume":"18","author":"Foster","year":"2012","journal-title":"RNA"},{"key":"ref_97","doi-asserted-by":"crossref","first-page":"e178","DOI":"10.1038\/mtna.2014.31","article-title":"A Conserved Target Site in HIV-1 Gag RNA is Accessible to Inhibition by Both an HDV Ribozyme and a Short Hairpin RNA","volume":"3","author":"Scarborough","year":"2014","journal-title":"Mol. Ther. Nucleic Acids"},{"key":"ref_98","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1007\/978-1-62703-730-3_3","article-title":"Design and Evaluation of Clinically Relevant SOFA-HDV Ribozymes Targeting HIV RNA","volume":"1103","author":"Scarborough","year":"2014","journal-title":"Methods Mol. Biol."},{"key":"ref_99","doi-asserted-by":"crossref","unstructured":"Scarborough, R.J., Adams, K.L., Del Corpo, O., Daher, A., and Gatignol, A. (2016). Evaluation of the Efficacy and Toxicity of RNAs Targeting HIV-1 Production for Use in Gene or Drug Therapy. J. Vis. Exp.","DOI":"10.3791\/54486-v"},{"key":"ref_100","doi-asserted-by":"crossref","first-page":"5297","DOI":"10.1128\/AAC.00949-15","article-title":"Effective Inhibition of HIV-1 Production by Short Hairpin RNAs and Small Interfering RNAs Targeting a Highly Conserved Site in HIV-1 Gag RNA Is Optimized by Evaluating Alternative Length Formats","volume":"59","author":"Scarborough","year":"2015","journal-title":"Antimicrob. Agents Chemother."},{"key":"ref_101","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1089\/nat.2012.0361","article-title":"RNA interference trigger variants: Getting the most out of RNA for RNA interference-based therapeutics","volume":"22","author":"Snead","year":"2012","journal-title":"Nucleic Acid Ther."},{"key":"ref_102","doi-asserted-by":"crossref","first-page":"550","DOI":"10.1126\/science.1068999","article-title":"A system for stable expression of short interfering RNAs in mammalian cells","volume":"296","author":"Brummelkamp","year":"2002","journal-title":"Science"},{"key":"ref_103","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1007\/978-1-62703-119-6_12","article-title":"Short hairpin RNA-mediated gene silencing","volume":"942","author":"Lambeth","year":"2013","journal-title":"Methods Mol. Biol."},{"key":"ref_104","doi-asserted-by":"crossref","first-page":"e161","DOI":"10.1038\/mtna.2014.12","article-title":"Pol III Promoters to Express Small RNAs: Delineation of Transcription Initiation","volume":"3","author":"Ma","year":"2014","journal-title":"Mol. Ther. Nucleic Acids"},{"key":"ref_105","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1080\/21541264.2017.1322170","article-title":"Mutation of nucleotides around the +1 position of type 3 polymerase III promoters: The effect on transcriptional activity and start site usage","volume":"8","author":"Gao","year":"2017","journal-title":"Transcription"},{"key":"ref_106","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1016\/j.omtn.2017.11.006","article-title":"Delineation of the Exact Transcription Termination Signal for Type 3 Polymerase III","volume":"10","author":"Gao","year":"2018","journal-title":"Mol. Ther. Nucleic Acids"},{"key":"ref_107","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1016\/S1525-0016(02)00037-0","article-title":"Simultaneous inhibition of GSK3\u03b1 and GSK3\u03b2 using hairpin siRNA expression vectors","volume":"7","author":"Yu","year":"2003","journal-title":"Mol. Ther."},{"key":"ref_108","doi-asserted-by":"crossref","first-page":"948","DOI":"10.1101\/gad.981002","article-title":"Short hairpin RNAs (shRNAs) induce sequence-specific silencing in mammalian cells","volume":"16","author":"Paddison","year":"2002","journal-title":"Genes Dev."},{"key":"ref_109","doi-asserted-by":"crossref","first-page":"715","DOI":"10.1002\/jgm.556","article-title":"Optimization of an siRNA-expression system with an improved hairpin and its significant suppressive effects in mammalian cells","volume":"6","author":"Miyagishi","year":"2004","journal-title":"J. Gene Med."},{"key":"ref_110","doi-asserted-by":"crossref","unstructured":"McIntyre, G.J., Yu, Y.H., Lomas, M., and Fanning, G.C. (2011). The effects of stem length and core placement on shRNA activity. BMC Mol. Biol., 12.","DOI":"10.1186\/1471-2199-12-34"},{"key":"ref_111","doi-asserted-by":"crossref","first-page":"1765","DOI":"10.1261\/rna.599107","article-title":"Defining the optimal parameters for hairpin-based knockdown constructs","volume":"13","author":"Li","year":"2007","journal-title":"RNA"},{"key":"ref_112","doi-asserted-by":"crossref","first-page":"1834","DOI":"10.1261\/rna.1062908","article-title":"Minimizing variables among hairpin-based RNAi vectors reveals the potency of shRNAs","volume":"14","author":"Boudreau","year":"2008","journal-title":"RNA"},{"key":"ref_113","doi-asserted-by":"crossref","first-page":"2811","DOI":"10.1093\/nar\/gkn109","article-title":"Inhibition of HIV-1 by multiple siRNAs expressed from a single microRNA polycistron","volume":"36","author":"Liu","year":"2008","journal-title":"Nucleic Acids Res."},{"key":"ref_114","doi-asserted-by":"crossref","first-page":"e127","DOI":"10.1093\/nar\/gkp657","article-title":"RNA polymerase III can drive polycistronic expression of functional interfering RNAs designed to resemble microRNAs","volume":"37","author":"Snyder","year":"2009","journal-title":"Nucleic Acids Res."},{"key":"ref_115","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1007\/978-1-61779-424-7_26","article-title":"Polycistronic expression of interfering RNAs from RNA polymerase III promoters","volume":"815","author":"Steel","year":"2012","journal-title":"Methods Mol. Biol."},{"key":"ref_116","doi-asserted-by":"crossref","first-page":"6652","DOI":"10.1093\/nar\/gkq460","article-title":"Deriving four functional anti-HIV siRNAs from a single Pol III-generated transcript comprising two adjacent long hairpin RNA precursors","volume":"38","author":"Saayman","year":"2010","journal-title":"Nucleic Acids Res."},{"key":"ref_117","doi-asserted-by":"crossref","first-page":"5683","DOI":"10.1093\/nar\/gkm596","article-title":"Design of extended short hairpin RNAs for HIV-1 inhibition","volume":"35","author":"Liu","year":"2007","journal-title":"Nucleic Acids Res."},{"key":"ref_118","doi-asserted-by":"crossref","first-page":"15163","DOI":"10.1073\/pnas.1006432107","article-title":"Conserved vertebrate mir-451 provides a platform for Dicer-independent, Ago2-mediated microRNA biogenesis","volume":"107","author":"Yang","year":"2010","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_119","doi-asserted-by":"crossref","first-page":"584","DOI":"10.1038\/nature09092","article-title":"A dicer-independent miRNA biogenesis pathway that requires Ago catalysis","volume":"465","author":"Cheloufi","year":"2010","journal-title":"Nature"},{"key":"ref_120","doi-asserted-by":"crossref","first-page":"1694","DOI":"10.1126\/science.1190809","article-title":"A novel miRNA processing pathway independent of Dicer requires Argonaute2 catalytic activity","volume":"328","author":"Cifuentes","year":"2010","journal-title":"Science"},{"key":"ref_121","doi-asserted-by":"crossref","first-page":"10369","DOI":"10.1093\/nar\/gkx779","article-title":"Dicer-independent processing of small RNA duplexes: Mechanistic insights and applications","volume":"45","author":"Berkhout","year":"2017","journal-title":"Nucleic Acids Res."},{"key":"ref_122","doi-asserted-by":"crossref","first-page":"3723","DOI":"10.1093\/nar\/gkt036","article-title":"Dicer-independent processing of short hairpin RNAs","volume":"41","author":"Liu","year":"2013","journal-title":"Nucleic Acids Res."},{"key":"ref_123","doi-asserted-by":"crossref","first-page":"e247","DOI":"10.1038\/mtna.2015.19","article-title":"Deep Sequence Analysis of AgoshRNA Processing Reveals 3\u2032 A Addition and Trimming","volume":"4","author":"Harwig","year":"2015","journal-title":"Mol. Ther. Nucleic Acids"},{"key":"ref_124","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1038\/gt.2017.44","article-title":"Silencing of HIV-1 by AgoshRNA molecules","volume":"24","author":"Harwig","year":"2017","journal-title":"Gene Ther."},{"key":"ref_125","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1186\/s13073-015-0174-y","article-title":"RNA interference approaches for treatment of HIV-1 infection","volume":"7","author":"Bobbin","year":"2015","journal-title":"Genome Med."},{"key":"ref_126","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1016\/j.addr.2016.03.005","article-title":"Recent advances in RNAi-based strategies for therapy and prevention of HIV-1\/AIDS","volume":"103","author":"Swamy","year":"2016","journal-title":"Adv. Drug Deliv. Rev."},{"key":"ref_127","doi-asserted-by":"crossref","first-page":"1491","DOI":"10.1016\/j.ymthe.2017.03.001","article-title":"Current Progress in Non-viral RNAi-Based Delivery Strategies to Lymphocytes","volume":"25","author":"Mizrahy","year":"2017","journal-title":"Mol. Ther."},{"key":"ref_128","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1111\/liv.13304","article-title":"Future anti-HBV strategies","volume":"37","author":"Gane","year":"2017","journal-title":"Liver Int."},{"key":"ref_129","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1038\/nature14442","article-title":"Lipid nanoparticle siRNA treatment of Ebola-virus-Makona-infected nonhuman primates","volume":"521","author":"Thi","year":"2015","journal-title":"Nature"},{"key":"ref_130","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1016\/j.healun.2015.08.012","article-title":"ALN-RSV01 for prevention of bronchiolitis obliterans syndrome after respiratory syncytial virus infection in lung transplant recipients","volume":"35","author":"Gottlieb","year":"2016","journal-title":"J. Heart Lung Transplant."},{"key":"ref_131","doi-asserted-by":"crossref","first-page":"921","DOI":"10.1126\/science.1152725","article-title":"Identification of host proteins required for HIV infection through a functional genomic screen","volume":"319","author":"Brass","year":"2008","journal-title":"Science"},{"key":"ref_132","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1016\/j.cell.2008.07.032","article-title":"Global analysis of host-pathogen interactions that regulate early-stage HIV-1 replication","volume":"135","author":"Konig","year":"2008","journal-title":"Cell"},{"key":"ref_133","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1016\/j.chom.2008.10.004","article-title":"Genome-scale RNAi screen for host factors required for HIV replication","volume":"4","author":"Zhou","year":"2008","journal-title":"Cell Host Microbe"},{"key":"ref_134","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1016\/B978-0-12-415795-8.00001-5","article-title":"Toward a durable treatment of HIV-1 infection using RNA interference","volume":"102","author":"Eekels","year":"2011","journal-title":"Prog. Mol. Biol. Transl. Sci."},{"key":"ref_135","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/j.antiviral.2010.11.005","article-title":"Long-term inhibition of HIV-1 replication with RNA interference against cellular co-factors","volume":"89","author":"Eekels","year":"2011","journal-title":"Antivir. Res."},{"key":"ref_136","doi-asserted-by":"crossref","first-page":"883","DOI":"10.1016\/j.ymthe.2006.07.007","article-title":"Silencing of HIV-1 with RNA interference: A multiple shRNA approach","volume":"14","author":"Konstantinova","year":"2006","journal-title":"Mol. Ther."},{"key":"ref_137","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1002\/jgm.1329","article-title":"Stringent testing identifies highly potent and escape-proof anti-HIV short hairpin RNAs","volume":"11","author":"Berkhout","year":"2009","journal-title":"J. Gene Med."},{"key":"ref_138","doi-asserted-by":"crossref","first-page":"2895","DOI":"10.1128\/JVI.02035-07","article-title":"Human immunodeficiency virus type 1 escape is restricted when conserved genome sequences are targeted by RNA interference","volume":"82","author":"Berkhout","year":"2008","journal-title":"J. Virol."},{"key":"ref_139","doi-asserted-by":"crossref","first-page":"e120","DOI":"10.1038\/mtna.2013.48","article-title":"Preclinical in vivo evaluation of the safety of a multi-shRNA-based gene therapy against HIV-1","volume":"2","author":"Centlivre","year":"2013","journal-title":"Mol. Ther. Nucleic Acids"},{"key":"ref_140","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1186\/1742-4690-4-80","article-title":"Optimal design and validation of antiviral siRNA for targeting HIV-1","volume":"4","author":"Naito","year":"2007","journal-title":"Retrovirology"},{"key":"ref_141","doi-asserted-by":"crossref","first-page":"936","DOI":"10.1093\/nar\/gkh442","article-title":"Guidelines for the selection of highly effective siRNA sequences for mammalian and chick RNA interference","volume":"32","author":"Naito","year":"2004","journal-title":"Nucleic Acids Res."},{"key":"ref_142","doi-asserted-by":"crossref","first-page":"326","DOI":"10.1038\/nbt936","article-title":"Rational siRNA design for RNA interference","volume":"22","author":"Reynolds","year":"2004","journal-title":"Nat. Biotechnol."},{"key":"ref_143","doi-asserted-by":"crossref","first-page":"1050","DOI":"10.1016\/j.bbrc.2004.02.157","article-title":"An algorithm for selection of functional siRNA sequences","volume":"316","author":"Amarzguioui","year":"2004","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"ref_144","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1186\/1742-4690-6-55","article-title":"96 shRNAs designed for maximal coverage of HIV-1 variants","volume":"6","author":"McIntyre","year":"2009","journal-title":"Retrovirology"},{"key":"ref_145","doi-asserted-by":"crossref","unstructured":"Ringpis, G.E., Shimizu, S., Arokium, H., Camba-Colon, J., Carroll, M.V., Cortado, R., Xie, Y., Kim, P.Y., Sahakyan, A., and Lowe, E.L. (2012). Engineering HIV-1-resistant T-cells from short-hairpin RNA-expressing hematopoietic stem\/progenitor cells in humanized BLT mice. PLoS ONE, 7.","DOI":"10.1371\/journal.pone.0053492"},{"key":"ref_146","doi-asserted-by":"crossref","first-page":"820","DOI":"10.1038\/mt.2011.299","article-title":"SHAPE-directed discovery of potent shRNA inhibitors of HIV-1","volume":"20","author":"Low","year":"2012","journal-title":"Mol. Ther."},{"key":"ref_147","doi-asserted-by":"crossref","first-page":"711","DOI":"10.1038\/nature08237","article-title":"Architecture and secondary structure of an entire HIV-1 RNA genome","volume":"460","author":"Watts","year":"2009","journal-title":"Nature"},{"key":"ref_148","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1007\/978-1-4939-2432-5_4","article-title":"Gene therapy strategies to block HIV-1 replication by RNA interference","volume":"848","author":"Berkhout","year":"2015","journal-title":"Adv. Exp. Med. Biol."},{"key":"ref_149","doi-asserted-by":"crossref","first-page":"796","DOI":"10.1093\/nar\/gki220","article-title":"HIV-1 can escape from RNA interference by evolving an alternative structure in its RNA genome","volume":"33","author":"Westerhout","year":"2005","journal-title":"Nucleic Acids Res."},{"key":"ref_150","doi-asserted-by":"crossref","unstructured":"Yukl, S.A., Boritz, E., Busch, M., Bentsen, C., Chun, T.W., Douek, D., Eisele, E., Haase, A., Ho, Y.C., and Hutter, G. (2013). Challenges in detecting HIV persistence during potentially curative interventions: A study of the Berlin patient. PLoS Pathog., 9.","DOI":"10.1371\/journal.ppat.1003347"},{"key":"ref_151","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1038\/mt.2013.264","article-title":"Genetically modified hematopoietic stem cell transplantation for HIV-1-infected patients: Can we achieve a cure?","volume":"22","author":"Younan","year":"2014","journal-title":"Mol. Ther."},{"key":"ref_152","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1016\/j.stem.2011.12.015","article-title":"Hematopoietic-stem-cell-based gene therapy for HIV disease","volume":"10","author":"Kiem","year":"2012","journal-title":"Cell Stem Cell"},{"key":"ref_153","doi-asserted-by":"crossref","first-page":"2898","DOI":"10.3390\/v5112898","article-title":"Development of hematopoietic stem cell based gene therapy for HIV-1 infection: Considerations for proof of concept studies and translation to standard medical practice","volume":"5","author":"DiGiusto","year":"2013","journal-title":"Viruses"},{"key":"ref_154","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1186\/s12977-015-0150-z","article-title":"The CRISPR\/Cas9 system inactivates latent HIV-1 proviral DNA","volume":"12","author":"Zhu","year":"2015","journal-title":"Retrovirology"},{"key":"ref_155","doi-asserted-by":"crossref","first-page":"2819","DOI":"10.1016\/j.celrep.2016.11.057","article-title":"A Combinatorial CRISPR-Cas9 Attack on HIV-1 DNA Extinguishes All Infectious Provirus in Infected T Cell Cultures","volume":"17","author":"Wang","year":"2016","journal-title":"Cell Rep."}],"container-title":["Viruses"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/1999-4915\/10\/1\/8\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T18:55:43Z","timestamp":1760208943000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/1999-4915\/10\/1\/8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,12,27]]},"references-count":155,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2018,1]]}},"alternative-id":["v10010008"],"URL":"https:\/\/doi.org\/10.3390\/v10010008","relation":{},"ISSN":["1999-4915"],"issn-type":[{"value":"1999-4915","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,12,27]]}}}